MedTrace Logo

Clinical Efficacy and Safety Evaluation of the Drug Imescard Compound Water Smartweed Pills

NCT00861562 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2009-03-13

No results posted yet for this study

Summary

The purpose of this study was to assess the clinical efficacy and safety of the drug Imescard water smartweed compound pills in the treatment of patients with chronic constipation and hemorrhoidal disease.

Conditions

Interventions

DRUG

Imescard water smartweed composed pills

01 pill at every 8 hours for 5 days.

DRUG

Placebo

01 pill at every 8 hours for 5 days, with the exact same appearance as the other intervention.

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-10-31
Completion
2009-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00861562 on ClinicalTrials.gov